<DOC>
	<DOCNO>NCT00004103</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug combine chemotherapy surgery may kill tumor cell . PURPOSE : This phase II trial study well irinotecan cisplatin follow surgery , floxuridine , cisplatin work treat patient stomach cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Followed Surgery Treating Patients With Stomach Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine complete partial response rate time treatment failure patient advance gastric cancer treat neoadjuvant irinotecan cisplatin follow surgery intraperitoneal floxuridine cisplatin . - Determine rate potentially curative surgery patient receive regimen . - Determine toxicity tolerance regimen patient . OUTLINE : Patients receive cisplatin IV irinotecan IV week 4 week . This course repeat 2 week later . Patients achieve complete partial remission stable disease undergo resection 4 week last chemotherapy dose . Patients residual macroscopic disease begin adjuvant intraperitoneal ( IP ) chemotherapy 1 week surgery . Chemotherapy consist floxuridine IP 30 minute day 1-3 day 22-24 cisplatin IP day 3 24 . PROJECTED ACCRUAL : A total 18-33 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Floxuridine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven , previously untreated gastric cancer Stage IB , II , III , IV ( T34 , N0 OR T , N12 , M0 ) No metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : SWOG 02 Life expectancy : Not specify Hematopoietic : WBC least 4000/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 9 g/dL Hepatic : Bilirubin le 2 mg/dL SGOT/SGPT great 2 time upper limit normal ( ULN ) Alkaline phosphatase great 3 time ULN PT , aPTT , TT normal No Gilbert 's disease Renal : BUN great 30 mg/dL Creatinine great 1.5 mg/dL OR Creatinine clearance great 60 mL/min Cardiovascular : No myocardial infarction within past 3 month No congestive heart failure require therapy Other : No invasive malignancy past 5 year except adequately treat basal squamous cell skin cancer carcinoma situ cervix No active uncontrolled infection HIV negative No severe concurrent disease No psychiatric disorder would preclude compliance Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy gastric cancer Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy gastric cancer Surgery : No prior surgery gastric cancer No emergent need surgery gastrointestinal obstruction , perforation , hemorrhage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>stage I gastric cancer</keyword>
	<keyword>stage II gastric cancer</keyword>
	<keyword>stage III gastric cancer</keyword>
	<keyword>stage IV gastric cancer</keyword>
</DOC>